Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants

7 Nov 2022

Abstract excerpt

The emergence of drug resistance significantly hampers the treatment of human infections, including those caused by fungal pathogens such as Candida species. Candida glabrata ranks as the second most common cause of candidiasis worldwide, supported by rapid acquisition of resistance to azole and echinocandin antifungals frequently prompted by single nucleotide polymorphisms (SNPs) in resistance associated genes,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Fungal Infections and Studies
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36448018
DOI: 10.15698/mic2022.11.786

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinantsPMID 36448018Read ↗

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates.Semantic proximity Read ↗

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.Semantic proximity Read ↗

Cg PDR 1 gain‐of‐function mutations lead to azole‐resistance and increased adhesion in clinical Candida glabrata strainsSemantic proximity Read ↗

Whole genome sequencing analysis of Candida glabrata isolates collected from patients with selected drug-resistant candidiasis hospitalized in Eastern Poland.Semantic proximity Read ↗

Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence TypesSemantic proximity Read ↗

Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpressionSemantic proximity Read ↗

Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.Semantic proximity Read ↗

Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata.Semantic proximity Read ↗

Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.Semantic proximity Read ↗

Disclosing azole resistance mechanisms in resistant Candida glabrata strains encoding wild-type or gain-of-function CgPDR1 alleles through comparative genomics and transcriptomics.Semantic proximity Read ↗

Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates.Semantic proximity Read ↗

Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of PDR1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.